Skip to content
zameds

Sildenafil (Myedra, Sildenafil Viatris)

Sildenafil

Oethmaan Biosims (Pty) Ltd

S4

Registration

Applicant
Oethmaan Biosims (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Myedra 25 MG

EACH TABLET CONTAINS: SILDENAFIL CITRATE EQUIVALENT TO SILDENAFIL 25,0 mg

25 mg47081847/7.1.5/0818RegisteredS4None
Myedra 50 MG

EACH TABLET CONTAINS: SILDENAFIL CITRATE EQUIVALENT TO SILDENAFIL 50,0 mg

50 mg47081947/7.1.5/0819RegisteredS4None
Myedra 100 MG

EACH TABLET CONTAINS: SILDENAFIL CITRATE EQUIVALENT TO SILDENAFIL 100,0 mg

100 mg47082047/7.1.5/0820RegisteredS4None
Sildenafil viatris

EACH TABLET CONTAINS: SILDENAFIL CITRATE EQUIVALENT TO SILDENAFIL 20,0 mg

20 mgFilm-coated tablets49109749/7.1.5/1097Approved 14 October 2024RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Sildenafil

  • S4: Sildenafil

    Consolidated Schedules 06 July 2026, line 7926

Pharmacological class: Vasodilators - peripheral. (class 7.1.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C22H30N6O4S474.60 g/mol

5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one

Drag to rotate. Structure from PubChem CID 135398744.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles